Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yunchen Luo
Liraglutide Improves Non-Alcoholic Fatty Liver Disease in Diabetic Mice by Modulating Inflammatory Signaling Pathways
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Related publications
Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
Frontiers in Pharmacology
Pharmacology
Melatonin Improves Non-Alcoholic Fatty Liver Disease via MAPK-JNK/P38 Signaling in High-Fat-Diet-Induced Obese Mice
Lipids in Health and Disease
Biochemistry
Endocrinology
Clinical Biochemistry
Metabolism
Diabetes
Lactobacillus Rhamnosus GG Protects Against Non-Alcoholic Fatty Liver Disease in Mice
PLoS ONE
Multidisciplinary
Non-Alcoholic Fatty Liver Disease and Disease Mongering
American Journal of Medicine
Medicine
Insulin Resistance in Non-Diabetic Patients With Non-Alcoholic Fatty Liver Disease: Sites and Mechanisms
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Treatment of Non-Alcoholic Fatty Liver Disease
Postgraduate Medical Journal
Medicine
Pentoxifylline Ameliorates Non-Alcoholic Fatty Liver Disease in Hyperglycaemic and Dyslipidaemic Mice by Upregulating Fatty Acid Β-Oxidation
Scientific Reports
Multidisciplinary
Non-Alcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease Might Boost Cardiovascular Disease Burden
Archives of Medical Science - Atherosclerotic Diseases
Headway and Hurdles in Non-Alcoholic Fatty Liver Disease
Lancet Gastroenterology and Hepatology, The
Hepatology
Gastroenterology